ComplianceOnline

Limited Sampling Indicates The Reasonable Possibility of Ubiquitous Exposure To The Phthalate DEHP In The U.S. Population

  • By: Edward J. Faeder, Ph.D., James Bruya, Ph.D., & Thomas H. Clarke Jr., J.D., M.S.
  • Date: May 28, 2013
Webinar All Access Pass Subscription Abstract:

Serendipity has often provided unanticipated insights into chemistry and toxicology, among other fields.

Developing a new defense strategy [FAEDER, BRUYA, & CLARKE, 2011] for a Proposition 65 [OEHHA, 2012A] case in California, the authors undertook a variety of QA/QC procedures to be assured that their test results regarding exposure to DEHP [TOXNET, 2012A] from the consumer product at issue had precision and validity. One such procedure was to ascertain if the test subjects had measurable DEHP on their hands prior to the test in which they handled the product at issue.
 

Bookmark and Share

Trending Compliance Trainings

Trial Master File and Clinical Data Management Regulated by FDA
By - Carolyn Troiano
On Demand Access Anytime
Good Documentation Practice and Record Keeping Regulations (FDA & EMA)
By - Dr. Afsaneh Motamed Khorasani
On Demand Access Anytime
GAMP Data Integrity 21 CFR Part 11 Training Course
By - Kelly Thomas
On Demand Access Anytime
NEW Reclamation Process - Fed Gov't Payments
By - Donna K Olheiser
On Demand Access Anytime
Understanding and Preparing for FDA Pharmaceutical Inspections
By - Michael Ferrante
On Demand Access Anytime
How to conduct an effective BSA Audit
By - Justin Muscolino
On Demand Access Anytime
Installation and Qualification of the Packaging Lines
By - John E Lincoln
On Demand Access Anytime
Best Sellers
You Recently Viewed
    Loading